332 related articles for article (PubMed ID: 11290772)
1. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.
Riley JL; Blair PJ; Musser JT; Abe R; Tezuka K; Tsuji T; June CH
J Immunol; 2001 Apr; 166(8):4943-8. PubMed ID: 11290772
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: the related molecules CD28 and inducible costimulator deliver both unique and complementary signals required for optimal T cell activation.
Gonzalo JA; Delaney T; Corcoran J; Goodearl A; Gutierrez-Ramos JC; Coyle AJ
J Immunol; 2001 Jan; 166(1):1-5. PubMed ID: 11123268
[TBL] [Abstract][Full Text] [Related]
3. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
[TBL] [Abstract][Full Text] [Related]
4. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation.
Kato T; Nariuchi H
J Immunol; 2000 Apr; 164(7):3554-62. PubMed ID: 10725710
[TBL] [Abstract][Full Text] [Related]
5. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
7. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
[TBL] [Abstract][Full Text] [Related]
8. PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production.
Okamoto N; Tezuka K; Kato M; Abe R; Tsuji T
Biochem Biophys Res Commun; 2003 Oct; 310(3):691-702. PubMed ID: 14550257
[TBL] [Abstract][Full Text] [Related]
9. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
10. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas TL; Bakker CY; Bluestone JA
J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
[TBL] [Abstract][Full Text] [Related]
12. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors.
Riley JL; Mao M; Kobayashi S; Biery M; Burchard J; Cavet G; Gregson BP; June CH; Linsley PS
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11790-5. PubMed ID: 12195015
[TBL] [Abstract][Full Text] [Related]
13. Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development.
Yagi J; Arimura Y; Dianzani U; Uede T; Okamoto T; Uchiyama T
J Immunol; 2003 Jul; 171(2):783-94. PubMed ID: 12847246
[TBL] [Abstract][Full Text] [Related]
14. ICOS costimulation: It's not just for TH2 cells anymore.
Sperling AI; Bluestone JA
Nat Immunol; 2001 Jul; 2(7):573-4. PubMed ID: 11429535
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte-associated antigen-4 inhibits integrin-mediated stimulation.
Gatta L; Calviello G; Di Nicuolo F; Pace L; Ubaldi V; Doria G; Pioli C
Immunology; 2002 Oct; 107(2):209-16. PubMed ID: 12383200
[TBL] [Abstract][Full Text] [Related]
16. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.
Coyle AJ; Lehar S; Lloyd C; Tian J; Delaney T; Manning S; Nguyen T; Burwell T; Schneider H; Gonzalo JA; Gosselin M; Owen LR; Rudd CE; Gutierrez-Ramos JC
Immunity; 2000 Jul; 13(1):95-105. PubMed ID: 10933398
[TBL] [Abstract][Full Text] [Related]
17. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
[TBL] [Abstract][Full Text] [Related]
18. CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism.
Toyooka K; Maruo S; Iwahori T; Yamamoto N; Tai XG; Abe R; Takahama Y; Murakami M; Uede T; Hamaoka T; Fujiwara H
Int Immunol; 1996 Feb; 8(2):159-69. PubMed ID: 8671600
[TBL] [Abstract][Full Text] [Related]
19. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
Masuyama J; Kaga S; Kano S; Minota S
J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human inducible costimulator ligand expression and function.
Aicher A; Hayden-Ledbetter M; Brady WA; Pezzutto A; Richter G; Magaletti D; Buckwalter S; Ledbetter JA; Clark EA
J Immunol; 2000 May; 164(9):4689-96. PubMed ID: 10779774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
